PHASE-I-II STUDY OF RADIOLABELED ANTIBODY INTEGRATED IN THE TREATMENT OF PRIMARY HEPATIC MALIGNANCIES

被引：95

作者：

ORDER, SE

KLEIN, JL

ETTINGER, D

ALDERSON, P

SIEGELMAN, S

LEICHNER, P

机构：

[1] JOHNS HOPKINS MED INST,DEPT RADIAT ONCOL,BALTIMORE,MD 21205

[2] JOHNS HOPKINS MED INST,DEPT MED ONCOL & IMMUNOL,BALTIMORE,MD 21205

[3] JOHNS HOPKINS MED INST,DEPT NUCL MED,BALTIMORE,MD 21205

[4] JOHNS HOPKINS MED INST,DEPT RADIOL SCI,BALTIMORE,MD 21205

[5] JOHNS HOPKINS MED INST,DEPT RADIAT PHYS,BALTIMORE,MD 21205

来源：

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 1980年 / 6卷 / 06期

关键词：

D O I：

10.1016/0360-3016(80)90226-6

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：703 / 710

页数：8

共 29 条

[1] LABELING OF PROTEINS TO HIGH SPECIFIC RADIOACTIVITIES BY CONJUGATION TO A I-125-CONTAINING ACYLATING AGENT - APPLICATION TO RADIOIMMUNOASSAY [J].

BOLTON, AE ;

HUNTER, WM .

BIOCHEMICAL JOURNAL, 1973, 133 (03) :529-538

[2]

BROWNELL GL, 1968, J NUC MED S1, P28

[3]

DILLMAN LT, 1975, MED INT RAD DOS MIRD, P5

[4]

ESHHAR T, 1974, P NATL ACAD SCI USA, V81, P3956

[5]

ETTINGER DS, 1979, CANCER TREAT REP, V63, P131

[6]

FALKSON G, 1978, CANCER, V42, P2149, DOI 10.1002/1097-0142(197811)42:5<2149::AID-CNCR2820420510>3.0.CO

[7]

2-5

[8]

FRIEDMAN M, 1979, CANCER-AM CANCER SOC, V44, P906, DOI 10.1002/1097-0142(197909)44:3<906::AID-CNCR2820440318>3.0.CO

[9]

2-9

[10] DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUES [J].

GOLD, P ;

FREEDMAN, SO .

JOURNAL OF EXPERIMENTAL MEDICINE, 1965, 121 (03) :439-+

← 1 2 3 →